Study Identifies Prestin as a Potential Biomarker for Tinnitus
A new study reveals elevated levels of the protein prestin in individuals with tinnitus, suggesting its role in the condition.
A recent study published in Otolaryngology has identified elevated serum levels of the protein prestin in individuals suffering from tinnitus. The observational cohort study involved 82 participants, including 41 with chronic bilateral non-pulsatile tinnitus and 41 control subjects. Participants underwent audiometry, personal noise dosimetry, Tinnitus Handicap Inventory (THI) assessment, and venipuncture to measure serum concentrations of prestin and other inner ear proteins.
Results indicated that serum prestin levels were significantly higher in tinnitus subjects compared to controls (P = .006), with this difference remaining significant after adjusting for age, hearing loss, and daily noise exposure (P = .003). No significant differences were found for the other proteins measured, including otoferlin, connexin 26 (CX26), and stereocilin. Notably, prestin and stereocilin levels showed a positive correlation across subjects (ρ = .51, P < .001), particularly within the tinnitus group.
Implications for Tinnitus Diagnosis
The findings support the hypothesis that prestin plays a role in the pathophysiology of tinnitus, marking a potential step towards developing objective diagnostic tools for this prevalent auditory disorder. Tinnitus affects approximately 15 percent of the global population, and until now, diagnosis has relied heavily on subjective reports from patients. The study suggests that measuring prestin levels could provide a more objective means of assessing tinnitus.
While the study presents promising evidence linking prestin to tinnitus, researchers caution that further investigation is needed to fully understand the relationship. The current findings do not establish a direct causal link, and the biomarker's reliability for diagnostic purposes remains to be validated in larger cohorts. Nonetheless, this research lays the groundwork for future studies aimed at exploring the role of prestin in tinnitus and its potential as a therapeutic target.
